A company that develops a platform for rapidly discovering agonist antibodies against receptor complexes of interest.

Diagonal Therapeutics

Diagonal Therapeutics is a biotech company pioneering a new approach to discovering and developing agonist antibodies. The Company's DIAGONAL platform combines proprietary computational and experimental techniques to overcome historical challenges associated with agonist antibody drug discovery. Diagonal's emerging pipeline – discovered using the DIAGONAL platform – has the potential to deliver life-changing therapies to patients including therapies for hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension. For more information, please visit www.diagonaltx.com.

COM:DIAGONALTX

Diagonal Therapeutics

market

industry

website

linkedin

investor of

Metrics